Revive Therapeutics Ltd (RVVTF)
0.0140
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Revive Therapeutics Total Assets (Quarterly): 9.727M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.727M |
| December 31, 2023 | 9.707M |
| September 30, 2023 | 10.14M |
| June 30, 2023 | 10.75M |
| December 31, 2022 | 10.20M |
| September 30, 2022 | 10.80M |
| June 30, 2022 | 13.24M |
| March 31, 2022 | 14.77M |
| December 31, 2021 | 17.62M |
| September 30, 2021 | 22.00M |
| June 30, 2021 | 24.04M |
| March 31, 2021 | 25.63M |
| December 31, 2020 | 8.429M |
| September 30, 2020 | 7.531M |
| June 30, 2020 | 6.048M |
| March 31, 2020 | 5.210M |
| December 31, 2019 | 0.9615M |
| September 30, 2019 | 1.165M |
| June 30, 2019 | 0.977M |
| March 31, 2019 | 1.230M |
| December 31, 2018 | 0.4089M |
| September 30, 2018 | 0.6375M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.8452M |
| March 31, 2018 | 1.131M |
| December 31, 2017 | 1.240M |
| September 30, 2017 | 1.254M |
| June 30, 2017 | 1.479M |
| March 31, 2017 | 1.732M |
| December 31, 2016 | 1.343M |
| September 30, 2016 | 1.699M |
| June 30, 2016 | 1.072M |
| March 31, 2016 | 0.6939M |
| December 31, 2015 | 0.8416M |
| September 30, 2015 | 1.448M |
| June 30, 2015 | 2.148M |
| March 31, 2015 | 2.447M |
| December 31, 2014 | 2.954M |
| September 30, 2014 | 1.048M |
| June 30, 2014 | 1.259M |
| March 31, 2014 | 1.491M |
| December 31, 2013 | 1.828M |
| September 30, 2013 | 0.2926M |
| June 30, 2013 | 0.1088M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.9615M
Minimum
Dec 2019
25.63M
Maximum
Mar 2021
11.00M
Average
10.14M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.461M |
| Shareholders Equity (Quarterly) | 7.266M |